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Abstract: Derivatives of 4-aminomethyl-l-phenylalanine with
aromatic oligoamide foldamers as sidechain appendages were
successfully charged on tRNA by means of flexizymes. Their
subsequent incorporation both at the C-terminus of, and
within, peptide sequences by the ribosome, was demonstrated.
These results expand the registry of chemical structures
tolerated by the ribosome to sidechains significantly larger
and more structurally defined than previously demonstrated.
Genetic code reprogramming has enabled the incorporation
of non-proteinogenic amino acids into peptides and proteins,
greatly expanding available structures, functions, and chem-
istries. Despite eons of evolution, the ribosome displays
startling tolerance towards residues significantly deviating
from the twenty canonical a-amino acids: d-,[1, 2] b-[3,4] and N-
methyl-[5] amino acids, and a-amino acids equipped with
bulky and exotic sidechains[6] have been charged on tRNA by
means of flexizymes and, when combined with a reconstituted
flexible in vitro translation (FIT) system,[7] have been riboso-
mally incorporated within a-peptides. Capitalizing on the
even greater tolerance of the ribosome during translation
initiation, exotic peptides,[8] terpenes[9] and, recently, non-
amino acid substrates[10, 11] and aromatic oligoamide foldam-
ers,[12,13] have been incorporated as the first unit of ribosomal
peptide synthesis to produce various types of hybrid mole-
cules.[14] Because of their strong propensity to adopt helical
conformations,[15] aromatic foldamers may transmit folding
information to the peptide and control its conformation.[16,17]
With masses up to 1 kDa, they constitute the bulkiest and
most rigid objects ever incorporated by the translation
machinery, including delivery to the ribosome and passage
through its exit tunnel. Having highlighted the tolerance of
the ribosome in translation initiation, we decided to explore
whether incorporation of abiotic foldamers was feasible in
positions other than the N-terminus of the peptide.
Herein, we demonstrate how aromatic foldamers
appended to the sidechain of a 4-(aminomethyl)-l-a-phenyl-
alanine residue (Amf) can be recognized by flexizymes and
ribosomally incorporated to produce peptide–foldamer
hybrids with unique architectures (Figure 1a). We thus
identified the most rigid and structurally defined sidechains
accepted by the ribosome machinery to date.[18,19] Overall,
these findings not only extend by a great degree what was
previously thought possible, but also call into question the
limitations of natureQs translational apparatus.
Oligoamides consisting of quinoline (Q) and pyridine (P)
monomers have been shown to fold into stable helices in
a broad range of solvents including water (Figure 1 b).[20,21]
Monomer P, which is more flexible and smaller than Q, was
previously shown to ameliorate translation efficiency,[12]
potentially by alleviating the conformational rigidity of the
resulting oligomer.[22] A series of short foldamers was
designed and synthesized to pursue the translation of
foldamer-type sidechains in a stepwise manner (Figure 1b).
To facilitate substrate recognition by flexizymes and owing to
the distinct nature of aromatic foldamers from the arsenal of
ribosomally incorporated, exotic amino acids, the foldamer
segments were appended at a remote position from the
peptide main chain, on the sidechain of Amf. A Gly spacer
was introduced as for earlier foldamer-based peptide initia-
tors.[12] Furthermore, having previously unveiled foldamer
sidechain-dependent behavior on both aminoacylation and
translation,[13] we set out to explore foldamers having either
positively or negatively charged sidechains. Amf(-Gly-folda-
mer) amino acids were activated as cyanomethyl esters and
the ability of flexizyme to load these new substrates onto
tRNA was assessed using an established protocol involving
microhelix RNA (Supporting Information, Figures S1–S3).[7]
The results of the aminoacylation reaction (Table 1) indicated
that for Amf(-Gly-Q-Ac) (1,2) and Amf(-Gly-Q2-Ac) (3,4),
the reaction proceeded adequately both with negatively
charged QAsp and positively charged QDap. In contrast, for
sequences including P, that is Amf(-Gly-QP-Ac) and Amf(-
Gly-QPQ-Ac), the reaction only worked with QDap (5,7). No
loading on tRNA was observed with QAsp (6,8). QDap was then
used to also test Amf(-Gly-Q3-Ac) (9), but this more rigid
sequence was found to be incompatible with the flexizyme.
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Aminoacylation of tRNA by Amf(-Gly-foldamer) thus
appears to depend on monomer charge, sequence, rigidity
or bulkiness, and perhaps solubility.
This dependency seems stronger than for the substrates
previously used for translation initiation. It may perhaps be
reduced by a longer spacer than Gly but this was not tested in
the context of this investigation and peptide elongation was
investigated with 1–5 and 7. Aiming at introducing aromatic
oligoamide-containing Amf residues both at the C-terminus
and within the sequence, we designed mRNA templates T1
and T2 encoding a peptide 14-mer and 15-mer, respectively
(Figure 2a). The ACC codon, originally coding for Thr, was
arbitrarily chosen and reprogrammed to code for the Amf(-
Gly-foldamer).
The Flag peptide sequence was encoded in both tem-
plates, either before or after ACC, to enable radiolabeling of
the peptide using [14C]-Asp, as well as purification. The
oligoamide–tRNA conjugates were supplemented into a FIT
system, from which Thr had been omitted, and the translation
reactions were subjected to Flag purification prior to
MALDI-TOF-MS analysis (Figure 2b). Amf bearing
a single Q monomer (1 and 2) could be incorporated at
both internal and C-terminal positions. The size and rigidity of
these sidechains is comparable to that of other large
previously reported residues.[23] Amf bearing two foldamer
units (3–5) was incorporated within the peptide sequence, but
only the positively charged, 3 and 5, were incorporated at the
C-terminus of the peptide. Overall, these results exceeded our
expectations given their size and aromatic nature.
Remarkably, we also observed the formation of the
desired peptide when Amf bearing an entire trimer (7) was
incorporated either at the C-terminus or within the sequence.
Though the expression level was modest (see below), com-
pound 7 is by far the most structurally complex sidechain
incorporated by the ribosome to date[18, 19] (Figure 2c). How-
ever, it is likely that the foldamer helix is unfolded during the
actual process of translation, as we have previously observed
the trend foldamers with lower helical propensities are
accepted by the ribosome with higher efficiency.[12, 13] As
well as having the ability to unfold, it could be important that,
when unfolded, 7 has a width comparable to that of the largest
canonical aromatic amino acids.
Incorporation of Amf derivatives 1–5 and 7 was then
quantified by means of radioisotopes (RI, Table 1, and
Supporting Information, Figures S4 and S5). It became
immediately apparent that, for both templates, the increase
in the size of the appended foldamer moiety resulted in
a decrease in the translation efficiency. Derivatives 1 and 2
were incorporated the best, followed by Amf bearing QQ and
PQ dimers (3 and 5, respectively) and finally Amf bearing the
QPQ trimer (7), which can span over a full helix turn. The
Table 1: The sequences of amino acid elongators used in this study and
their acylation yields and translation efficiencies. (N.D. indicates the
product was detected but the yield was not determined)
Entry Foldamer sequence Acylation yield [%] Translation
yield [%][a]
T1 T2
1 Amf(-Gly-QDap-Ac) 20 92 68
2 Amf(-Gly-QAsp-Ac) 55 82 62
3 Amf(-Gly-(QDap)2-Ac) 24 48 11
4 Amf(-Gly-(QAsp)2-Ac) 29 – N.D.
[b]
5 Amf(-Gly-QDapP-Ac) 24 35 10
6 Amf(-Gly-QAspP-Ac) 0 – –
7 Amf(-Gly-QDapPQDap-Ac) 10 5 N.D.[b]
8 Amf(-Gly-QAspPQAsp-Ac) 0 – –
9 Amf(-Gly-(QDap)3-Ac) 0 – –
[a] The values provided are based on the observed incorporation
efficiency when compared with the wild type expression (absence of
reprogramming). [b] Low yields and band overlap hampered their
identification and subsequent quantification (Supporting Information,
Figures S4 and S5).
Figure 1. a) Schematic illustration of the ribosomal incorporation of
amino acids bearing helical aromatic foldamers (left) at the N-
terminus and (right) within a peptide sequence. b) Aromatic foldamer
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incorporation of negatively charged Amf(-Gly-(QAsp)2-Ac) 4
did not yield the desired product in a sufficient amount,
hampering its quantification. A comparison of the incorpo-
ration efficiency for the Amf-bearing monomers (1 and 2) and
homodimers (3 and 4) clearly indicates that oligoamides
composed of QDap are incorporated better than their QAsp
analogues, which is consistent with our recent studies on
translation initiation.[13]
The translated products were systematically accompanied
by a truncated peptide, which depended on the template,
shedding light on different aspects of elongation. The
truncated peptides obtained with template T1 (Figure 2b)
revealed some difficulty in forming the Ala–Amf peptide
bond: the peptide is truncated before Amf. This could come
from poor delivery of Amf–tRNA to the ribosome. It may
also be that the a-amine of Amf, once accommodated at the
A-site, cannot easily attack the peptidyl tRNA ester bond in
the peptidyl transferase center. Even though the foldamer
unit is remote from the a-amino group of Amf, its bulk could
result in unproductive presentation of the a-amine (Fig-
ure 2d). The truncated peptides obtained with template T2,
further highlight the difficulty to form the Ala–Amf bond
(Figure 2d): a-amino acid residues that precede Amf are
missing in the truncated sequence. Intriguingly, however, this
does not prevent the sequence from being further elongated.
Amf–tRNA must somehow move to the P-site and elongation
starts again from there. Formation of similar truncated
peptides has been observed during the incorporation of
certain d-amino acids.[1] For all substrates tested, excluding
substrate 4, the incorporation efficiency is higher with T1 than
with T2 (Table 1). C-terminal incorporation of Amf-foldam-
ers thus appears to be more efficient than elongation but this
hypothesis has not been investigated in detail.
Encouraged by these results, we set out to incorporate
more than one foldamer-containing Amf residue, either
consecutively or spaced by one or two Ala residues. We
thus designed templates T3–T8 (Figure 3), coding for pep-
tides with two Amf residues at different positions. Remark-
ably, translation was successful in all cases with substrates 1
and 2, which contain one quinoline unit. With substrate 5,
which contains a PQ segment, translation was successful only
when Amf residues were not consecutive. Quantification
experiments with substrates 1 and 2 also showed that yields
increase upon appropriate spacing between Amf residues
(Supporting Information, Figures S5 and S6, and Table S1).
The double incorporation of larger substrate 3 failed in all
cases, in contrast with its single incorporation. Even larger
substrates were not tested.
Finally, we challenged the ribosome to combine a quino-
line unit as the initiator, a second one appended within the
peptide sequence, and a final one with a different sidechain
appended at the C-terminus of the peptide, in a cyclic
thioether peptide. ClAc-QDap-Gly-Phe-CME was charged on




a Met-free and Thr-free FIT system for the translation of T9
(Figure 4a). This template also encodes for a Cys meant to
react with the N-terminal chloroacetamide to form the
aromatic oligoamide–peptide hybrid macrocycle.[24] The cor-
rect topology of the hybrid macrocycle was further confirmed
by using a similar template but lacking the Cys residue (T2).
The absence of cyclization (Supporting Information, Fig-
ure S9) validated the selective thiol-chloroacetyl reaction on
Figure 2. a) Template-encoded peptides containing Amf(-Gly-foldamer)
at the C-terminus (from T1) and within the peptide (from T2). “Flag”
stands for DYKDDDDK. b) Characteristic MALDI-TOF-MS spectra of
resulting peptides containing 1, 3, 5 or 7 as a positively charged
foldamer sidechain. Desired products are indicated by green and blue
peaks. Side-products corresponding to unsuccessful peptidyl trans-
ferase reactions are indicated by red and orange peaks (magnification
of the peaks corresponding to the desired products, along with the
[M+Na]+ and [M+K]+ are available in the Supporting Information).
c) Molecular model of Ala-Amf(-Gly-QDapPQDap-Ac)-Ala illustrating the
size of the foldamer with respect to the peptide chain (left) and its
extended chemical structure (right). Nonpolar hydrogen atoms have
been omitted for clarity. d) Scheme of the nucleophilic addition of the
foldamer-containing Amf residue on the peptidyl tRNA ester at the P-
site. e) Nucleophilic addition of the Ala amine following the Amf
residue. In (d) and (e) green circles and rounded squares represent
elongating amino acids and aromatic residues on Amf, respectively.
The red dashed part of the reaction arrow represents potential
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template T9. Despite the presence of a small number of
truncated products, the complex macrocycle shown in Fig-
ure 4b was indeed the major product, highlighting the
potential of the ribosome to assemble polymers from amino
acids significantly deviating from its original substrates.
In summary, we have shown that the ribosome tolerates
short foldamers not only as an initiation unit but also as
a sidechain appendage within or at the C-terminus of
a peptide. Foldamer-containing initiation and elongation
units may be even combined to generate novel foldamer–
peptide hybrids. The sidechain of Amf(-Gly-QPQ-Ac), which
spans a full foldamer helix turn, is by far the largest and most
structurally defined ever incorporated within a peptide
sequence by the ribosome. Multiple directions exist to further
improve the breadth of these reactions including, but not
limited to, the optimization of tRNA units.[2, 25,26] Interest in
increasing the diversity of mRNA-encoded chemical entities
is driven by the possibility to implement selection from very
large libraries. Non-peptidic features may enhance resistance
to protease degradation, cell penetration or, in the case of
foldamers, conformational control. The benefits of foldamers
in this respect are currently being investigated.
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